Arformoterol Tartrate Solution
Product Images NDC 70748-175

11 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Arformoterol Tartrate (NDC 70748-175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (9e59e677 5b11 43bf 947a C4d5d8c9b710 01)

Image (9e59e677 5b11 43bf 947a C4d5d8c9b710 01)
Chemical structure diagram of Arformoterol tartrate, showing the molecular arrangement of the active ingredient Arformoterol tartrate used in the respiratory inhalation solution formulation by Lupin Pharmaceuticals.*
FDA Label Image

Image (9e59e677 5b11 43bf 947a C4d5d8c9b710 02)

Image (9e59e677 5b11 43bf 947a C4d5d8c9b710 02)
A line graph showing mean change from baseline FEV1 (L) over 12 hours postdose comparing placebo and 15 mcg Arformoterol Tartrate Inhalation Solution BID. The graph depicts FEV1 values on the y-axis and hours postdose on the x-axis, with Arformoterol demonstrating greater positive FEV1 changes than placebo across all time points.*
FDA Label Image

Image (9e59e677 5b11 43bf 947a C4d5d8c9b710 03)

Image (9e59e677 5b11 43bf 947a C4d5d8c9b710 03)
A line graph showing mean change from baseline FEV1 (in liters) over 12 hours postdose comparing placebo and 15 mcg Arformoterol Tartrate inhalation solution BID. The x-axis represents hours postdose and the y-axis represents mean change in FEV1. Data show an increase in FEV1 for Arformoterol Tartrate compared to placebo, which remains near zero.*
FDA Label Image

Image (9e59e677 5b11 43bf 947a C4d5d8c9b710 04)

Image (9e59e677 5b11 43bf 947a C4d5d8c9b710 04)
An instructional illustration showing a hand gripping and twisting the top of a small vial or ampule, indicating the method to open the vial by bending or snapping the top off for use.*
FDA Label Image

Image (9e59e677 5b11 43bf 947a C4d5d8c9b710 05)

Image (9e59e677 5b11 43bf 947a C4d5d8c9b710 05)
An instructional illustration showing a hand holding and dispensing liquid from a dropper or pipette into a labeled reservoir chamber, indicating where to add the solution.*
FDA Label Image

Image (9e59e677 5b11 43bf 947a C4d5d8c9b710 06)

Image (9e59e677 5b11 43bf 947a C4d5d8c9b710 06)
An instructional diagram showing a respiratory inhalation device with the mouthpiece labeled. The device appears to be designed for administering a liquid solution via inhalation.*
FDA Label Image

Figure 4 (9e59e677 5b11 43bf 947a C4d5d8c9b710 07)

Figure 4 (9e59e677 5b11 43bf 947a C4d5d8c9b710 07)
An instructional illustration showing a face mask attached to a respiratory solution delivery device, likely demonstrating how the solution is inhaled through the mask.*
FDA Label Image

Image (9e59e677 5b11 43bf 947a C4d5d8c9b710 08)

Image (9e59e677 5b11 43bf 947a C4d5d8c9b710 08)
An instructional illustration showing a compressor device with a connected tubing piece, labeled to indicate the compressor and the tubing attachment points. This is likely related to respiratory inhalation treatment setup for the Arformoterol tartrate solution.*
FDA Label Image

Image (9e59e677 5b11 43bf 947a C4d5d8c9b710 09)

Image (9e59e677 5b11 43bf 947a C4d5d8c9b710 09)
An illustration showing a person using a respiratory inhalation device. The person is placing the inhaler mouthpiece into their mouth, demonstrating correct inhalation technique for a respiratory solution.*
FDA Label Image

Pouch (9e59e677 5b11 43bf 947a C4d5d8c9b710 10)

Pouch (9e59e677 5b11 43bf 947a C4d5d8c9b710 10)
Label for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL sterile unit-dose vial, distributed by Lupin Pharmaceuticals, Inc. The label includes dosage strength, storage instructions, usage warnings, and barcodes, with directions for proper storage and administration.*
FDA Label Image

Carton (9e59e677 5b11 43bf 947a C4d5d8c9b710 11)

Carton (9e59e677 5b11 43bf 947a C4d5d8c9b710 11)
Packaging label for Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, a respiratory inhalation solution by Lupin Pharmaceuticals, Inc. The label indicates Rx only, includes storage instructions to keep refrigerated or at room temperature for up to 6 weeks, and states that the package contains 30 sterile unit-dose vials of 2 mL each.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.